Intuitive Surgical Inc EVP and Chief Manufacturing and Supply Chain Officer Mark Brosius filed a Form 4 on November 18, 2026, disclosing three consecutive days of common stock sales totaling 138 shares under a Rule 10b5-1 trading plan.
Key Highlights
- Three sales over three days: Brosius disposed of 46 shares on each of November 16, 17, and 18, 2026, for a combined total of 138 shares.
- Prices declined each day: Shares were sold at $444.38 on November 16, $437.33 on November 17, and $430.63 on November 18, according to the filing.
- Remaining direct ownership: Following the three transactions, Brosius directly held 319 shares of Intuitive Surgical common stock, the filing reported.
- Rule 10b5-1 plan: The filing states all transactions took place under a trading plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
- Reporting person role: Brosius is identified in the filing as EVP and Chief Manufacturing and Supply Chain Officer of NASDAQ:ISRG.
Brosius Common Stock Dispositions at Intuitive Surgical, November 2026
Mark Brosius, Executive Vice President and Chief Manufacturing and Supply Chain Officer of Intuitive Surgical Inc (NASDAQ:ISRG), reported the sale of common stock across three trading sessions in November 2026. According to the Form 4 filed on November 18, 2026, each of the three transactions involved exactly 46 shares disposed of with transaction code "S," indicating open-market sales.
The filing discloses that shares were sold at $444.38 on November 16, 2026, reducing direct beneficial ownership from an implied pre-transaction figure to 411 shares. On November 17, 2026, an additional 46 shares were sold at $437.33, leaving Brosius with 365 shares. On November 18, 2026, a further 46 shares were sold at $430.63, bringing his directly held total to 319 shares following all reported transactions.
All three sales are attributed in the filing to a written trading plan. The filing's footnote states: "The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027." No derivative securities transactions were reported in Table II of the filing. The form was signed by Stephanie Lim-Ignacio on behalf of Brosius and dated November 18, 2026.
What Was Disclosed
The filing reports three Rule 10b5-1 plan sales of Intuitive Surgical common stock by EVP Mark Brosius on November 16, 17, and 18, 2026, totaling 138 shares at prices ranging from $430.63 to $444.38, with 319 shares remaining in direct ownership.



Please wait processing your request...